SANGUINE CORP. (SGNC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Prospector who wrote (3848)	9/2/1998 6:08:00 PM
From: Mongo2116	Read Replies (3) of 5402

Prospector +ALL...It is understandable that SGNC has to go thru certain steps to get where they are hoping to go, and that biotech is a waiting(on results) game. Are there examples of biotechs who traded OTC under a buck that eventually made it to their goal, and what did it do to the stock price? It appears to me that biotech will be in stronger and stronger favor as time goes on, due to a speedier approval time and demand for products that these companies are attempting to bring to market. A 2001 time goal to bring to market is reachable these days if tests go OK. If they get past testing the critters, this will be looked at as a contender for the substitute market, instead of a hoping to run. GIDDYUP!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next